Delcath Systems, Inc.

Healthcare

NASDAQ:DCTH · NASDAQ Capital Market

Market Cap $411.84M Beta 0.52 P/E (TTM) 751.4

$11.69 -1.91%

-$0.23 today

52W Low $8.12High $14.48

Vol 0.52M · Avg 0.42M

EPS (TTM) $0.02Medical - Devices

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

-11.84%

Period High

$14.05

Period Low

$8.19

Latest

$11.69

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Agilon Health, Inc.

NYSE:AGL

$1.80B

Tactile Systems Technology, Inc.

NASDAQ:TCMD

$593.91M

BrainsWay Ltd.

NASDAQ:BWAY

$567.16M

Cerus Corporation

NASDAQ:CERS

$531.98M

NeuroPace, Inc.

NASDAQ:NPCE

$521.29M

908 Devices Inc.

NASDAQ:MASS

$332.39M

Semler Scientific, Inc.

SMLR

$310.75M

Senseonics Holdings, Inc.

NASDAQ:SENS

$275.00M

RxSight, Inc.

NASDAQ:RXST

$194.77M

Nakamoto Inc.

NASDAQ:NAKA

$72.04M

What is the latest DCTH filing?

The latest filing shown is 4 dated May 14, 2026.

How many recent filings does DCTH have?

Intrinsic Alpha currently shows 20 recent filings for DCTH.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.